中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2009年
8期
1002-1003
,共2页
贺军%王艳%姜浩%唐静波%李珍发%张阳德
賀軍%王豔%薑浩%唐靜波%李珍髮%張暘德
하군%왕염%강호%당정파%리진발%장양덕
癌,肝细胞%甲胎蛋白%小干扰RNA%质粒载体
癌,肝細胞%甲胎蛋白%小榦擾RNA%質粒載體
암,간세포%갑태단백%소간우RNA%질립재체
Carcinoma,hepatoceUular%AFP%Small interfering RNA%Plasmid vector
目的 构建AFP增强子调控的小干扰RNA质粒载体.方法 从HePG2细胞中提取AFP基因.采用定向克隆的方法,构建质粒pGenesil-AFP.pGenesil-AFP质粒DNA扩增、提取后转化到DH5感受态细胞.针对目的 基因Survivin的序列,构建pGenesil-AFP-shRNA.结果 pGen-esil-AFP-shRNA质粒经XbaI和Hind Ⅲ双酶切鉴定,获得一856 bp大小和4506 bp大小的片段,通过基因测序分析,证明质粒载体构建正确,用紫外分光光度计测得质粒的浓度为1.3 g/L,A值为1.94,说明制备的质粒纯度较高.结论 成功构建AFP增强子调控的Survivin shRNA融合质粒.
目的 構建AFP增彊子調控的小榦擾RNA質粒載體.方法 從HePG2細胞中提取AFP基因.採用定嚮剋隆的方法,構建質粒pGenesil-AFP.pGenesil-AFP質粒DNA擴增、提取後轉化到DH5感受態細胞.針對目的 基因Survivin的序列,構建pGenesil-AFP-shRNA.結果 pGen-esil-AFP-shRNA質粒經XbaI和Hind Ⅲ雙酶切鑒定,穫得一856 bp大小和4506 bp大小的片段,通過基因測序分析,證明質粒載體構建正確,用紫外分光光度計測得質粒的濃度為1.3 g/L,A值為1.94,說明製備的質粒純度較高.結論 成功構建AFP增彊子調控的Survivin shRNA融閤質粒.
목적 구건AFP증강자조공적소간우RNA질립재체.방법 종HePG2세포중제취AFP기인.채용정향극륭적방법,구건질립pGenesil-AFP.pGenesil-AFP질립DNA확증、제취후전화도DH5감수태세포.침대목적 기인Survivin적서렬,구건pGenesil-AFP-shRNA.결과 pGen-esil-AFP-shRNA질립경XbaI화Hind Ⅲ쌍매절감정,획득일856 bp대소화4506 bp대소적편단,통과기인측서분석,증명질립재체구건정학,용자외분광광도계측득질립적농도위1.3 g/L,A치위1.94,설명제비적질립순도교고.결론 성공구건AFP증강자조공적Survivin shRNA융합질립.
Objective To construct an AFP enhancer-regulated siRNA expression plasmid vector.Methods The AFP gene was extracted from HePG2 cells, constructing plasmid PGenesil-AFP by orientation cloned.After DNA extraction and amplification, Plasrnid pGenesil-AFP was transformed into competent cell of DHS.Constructing plasmid vector pGenesil-AFP-shRNA to aim at the target gone sruvivin' s sequence.Results After p]asmid pGenesil-AFP-shRNA evaluated by gene sequencing analysis and enzyme cutting with both XbaⅠ and Hind Ⅲ, obtain a fragment of 856 bp and a fragment of 4506 bp.It is prove that Plasmid can be successfully constructed.Measured by ultraviolet spectrophotometer, the concentration of plasmid is 1.3 g/L and A value is 1.94.This shows that the purity of plasmid is high.Conclusion The successful construction of an AFP enhancer-regulated survivin shRNA integration plasmid.